Published: 16 March 2026
Author(s): Lærke Kristine Kyhl, Børge Grønne Nordestgaard, Anne Tybjærg-Hansen, Michael Huy Cuong Pham, Jørgen Tobias Kühl, Klaus Fuglsang Kofoed, Sune Fallgaard Nielsen
Section: Original Article
The rise in global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has highlighted the importance of developing sex-specific risk profiles for MASLD based on readily available self-reported lifestyle characteristics and plasma biomarkers.
